General Practice · Pasadena, CA
NPI
1073650925
Since 2007
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1710 E Washington Blvd
Pasadena, CA, 91104
Phone (626) 345-9022
Groups this clinician bills Medicare through
Medicare paid, 2024
$352K
8,451 services
Medicare patients, 2024
478
Average age 73
Drug cost, 2024
$2.2M
16,025 prescriptions
Company payments, 2024
$64.34
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Violeta M Navasardian was code J0585 (injection, onabotulinumtoxina, 1 unit), 3,455 times for 30 patients. In total Violeta M Navasardian billed 8,451 services in 42 codes, and Medicare paid $352K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 3,455 | 30 | $4.76 | $16K |
| 99213 Office E&M - Established | Office | 1,855 | 453 | $73.34 | $136K |
| 99203 Office E&M - New | Office | 378 | 378 | $82.96 | $31K |
| 36415 Venipuncture Blood Collection | Office | 302 | 231 | $8.65 | $2,612 |
| 93923 Duplex Scan - Extremity Arteries | Office | 276 | 131 | $101.05 | $28K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 258 | 258 | $20.09 | $5,183 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 248 | 248 | $133.60 | $33K |
| 99497 Care Management/Coordination | Office | 207 | 184 | $65.20 | $13K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 193 | 193 | $20.09 | $3,877 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 189 | 159 | $84.92 | $16K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 181 | 154 | $44.26 | $8,011 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 180 | 165 | $35.03 | $6,306 |
| 93040 Electrocardiogram | Office | 144 | 134 | $10.73 | $1,545 |
| 95923 Electrical Nerve Conductivity | Office | 144 | 134 | $103.96 | $15K |
| 95924 Electrical Nerve Conductivity | Office | 144 | 134 | $126.20 | $18K |
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 302 | 231 | $8.65 | $2,612 |
| 82962 Clinical Chemistry | 11 | 11 | $3.21 | $35.31 |
Medicare prescription drug claims, 2024
In 2024, the drug Violeta M Navasardian prescribed most often to Medicare patients was Amlodipine Besylate, with 568 prescriptions and refills. In total Violeta M Navasardian wrote 16,025 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 568 | 586 | 101 | $821 |
| Atorvastatin Calcium Generic | 540 | 560 | 98 | $1,551 |
| Gabapentin Generic | 499 | 511 | 93 | $1,491 |
| Metformin Hcl Generic | 457 | 479 | 81 | $8,274 |
| Omeprazole Generic | 425 | 432 | 76 | $1,128 |
| Tamsulosin Hcl Generic | 405 | 425 | 66 | $1,684 |
| Ibuprofen Generic | 369 | 379 | 75 | $2,084 |
| Vascepa Icosapent Ethyl | 367 | 383 | 65 | $107K |
| Rosuvastatin Calcium Generic | 332 | 352 | 60 | $1,347 |
| Levothyroxine Sodium Generic | 329 | 335 | 55 | $1,345 |
| Alendronate Sodium Generic | 314 | 329 | 52 | $776 |
| Meclizine Hcl Generic | 303 | 310 | 54 | $1,585 |
| Carvedilol Generic | 293 | 309 | 48 | $624 |
| Simvastatin Generic | 290 | 302 | 46 | $528 |
| Losartan Potassium Generic | 268 | 279 | 46 | $643 |
Brand drugs: 2,435 claims; generic drugs: 13,332 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Violeta M Navasardian $64.34 ($64.34 in general payments such as food, travel and fees) from 1 company. The largest payer was Revance Therapeutics, Inc. with $64.34.
| Company | Payments | Amount |
|---|---|---|
| Revance Therapeutics, Inc. | 1 | $64.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.